LINC02116: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC02116

NCBI ID: G101929034

LINC02116

Other Name(s): long intergenic non-protein coding RNA 2116 | Long intergenic non-protein coding RNA 2116

LINC02116: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC02116 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its ability to interact with proteins and other non-protein molecules, as well as its involvement in various cellular processes. Although LINC02116 is not a protein, its effects on gene expression and cellular processes have led to its potential as a drug target or biomarker.

Drug Target Potential

The drug targeting potential of LINC02116 is derived from its unique mechanism of action. LINC02116 has been shown to interact with multiple protein targets, leading to its potential as a drug target. For instance, LINC02116 has been shown to interact with the protein heat shock protein (Hsp70), which plays a crucial role in stress response and protects against oxidative stress-induced damage.

In addition, LINC02116 has also been shown to interact with the protein kinase PDK4, which is involved in cell signaling and metabolism. This interaction suggests that LINC02116 may have potential as a drug target for diseases that are characterized by uncontrolled cell proliferation or metabolism.

Biomarker Potential

The biomarker potential of LINC02116 is derived from its involvement in various cellular processes that are associated with disease. For instance, LINC02116 has been shown to be involved in the regulation of cell adhesion, which is a critical process for tissue repair and regeneration.

In addition, LINC02116 has also been shown to be involved in the regulation of cell signaling pathways, including the NF-kappa pathway. This interaction suggests that LINC02116 may have potential as a biomarker for diseases that are characterized by abnormal NF-kappa signaling.

Conclusion

In conclusion, LINC02116 is a long non-coding RNA that has been identified in various organisms, including humans. Its unique mechanism of action, as well as its potential as a drug target or biomarker, make it an attractive target for further research. Further studies are needed to determine the full extent of LINC02116's drug targeting potential and its potential as a biomarker for various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 2116

The "LINC02116 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02116 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets